Wearable Robotics
Wearable Robotics develops exoskeletons and robotic rehabilitation devices for neuro-motor rehabilitation and assistance, operating in both biomedical and industrial divisions with a specific emphasis on utilizing wearable robots to enhance sensorimotor functions. The company's flagship product ALEx RS is an innovative robotic exoskeleton with 5 degrees of freedom (4 active and 1 passive) for upper limb…
Funding snapshot
About
Wearable Robotics develops exoskeletons and robotic rehabilitation devices for neuro-motor rehabilitation and assistance, operating in both biomedical and industrial divisions with a specific emphasis on utilizing wearable robots to enhance sensorimotor functions. The company's flagship product ALEx RS is an innovative robotic exoskeleton with 5 degrees of freedom (4 active and 1 passive) for upper limb rehabilitation, based on a novel tendon-actuated transmission design that grants patients extreme wearability, low weight, and high transparency during use, and is a CE certified medical device of class IIa. The company also offers ALEx S (Track-Hold), a rehabilitation device for upper limb passive training with gravity compensation in spatial movements, featuring motion tracking of full arm movement through embedded position sensing technologies that facilitate movement execution in patients with hemiparesis. Wearable Robotics' research and development projects include MMC EXOS, TRACKHOLD, WEARABLE WALKER, EXO.CARE, and ALEx RS 2.0, with active research partnerships and publications in the rehabilitation robotics field. The company's vision is to lead the wearable robotics market by offering cutting-edge robotic solutions that revolutionize physical rehabilitation and support, pushing the boundaries of technology for physical assistance and rehabilitation with a focus on helping people regain their freedom of movement. Founded in 2014 and headquartered in Pisa, Italy, Wearable Robotics has raised approximately $8.5 million at the Series A stage from investors including Progress Tech Transfer, ClubDealOnline, LIFTT, RoboIT, Europa, CDP Venture Capital, MITO Technology, Simest, Toscana Next Fund, and iStarter.
Business model
Wearable Technology > Health and Wellness Devices > Rehabilitation,
Professional Service Robots > Healthcare > Rehabilitation,
Assistive Tech > Assistive Hardware > Mobility > Powered exoskeletons,
Orthopedics > Medical Devices > Therapies > Rehabilitation > Exoskeleton
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.